Jennifer S. Guimbellot

Pediatric Pulmonology

1 Childrens Way
Little Rock, AR 72202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Generic and Biosimilar Prescribing in Children and Adolescents: Policy Statement.

Generic and Biosimilar Prescribing in Children and Adolescents: Policy Statement.

Journal: Pediatrics

Published: May 25, 2026

Generic and Biosimilar Prescribing in Children and Adolescents: Technical Report.

Generic and Biosimilar Prescribing in Children and Adolescents: Technical Report.

Journal: Pediatrics

Published: May 25, 2026

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

Journal: The European respiratory journal

Published: August 09, 2025

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis.

Impact of CFTR modulator concentrations on clinical response in cystic fibrosis.

Journal: The European respiratory journal

Published: July 30, 2025

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad.

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: June 19, 2025

Shifting Nutrition Paradigms: Changing Attitudes Towards Diet and Body Perceptions Among People With CF in the Era of Highly Effective Modulators.

Shifting Nutrition Paradigms: Changing Attitudes Towards Diet and Body Perceptions Among People With CF in the Era of Highly Effective Modulators.

Journal: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association

Published: April 22, 2025

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 14, 2025

Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy.

Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy.

Journal: Pediatric pulmonology

Published: February 15, 2025

Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.

Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 17, 2024

Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant.

Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplant.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 05, 2024

Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial.

Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial.

Journal: American journal of respiratory and critical care medicine

Published: September 24, 2024

Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosis.

Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosis.

Journal: Pharmacotherapy

Published: August 22, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026